tiprankstipranks
Can-Fite BioPharma (CANF)
NYSE MKT:CANF

Can-Fite BioPharma (CANF) Stock Investors

483 Followers
Based on 746,321 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CANF
On average, investors allocate 0.00% of their portfolios to CANF
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 746,321 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CANF

6.2%
Last 7
Days
17.1%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CANF, out of 746,321 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CANF Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,167 investors who made their portfolios public
The table shows changes in CANF in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CANF Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
5.80%
-1.24%
-1.57%
34.65B
Consumer Cyclical
ChargePoint Holdings
4.22%
-1.01%
-2.40%
927.16M
Consumer Cyclical
Riot Platforms
4.90%
-0.84%
+0.64%
3.32B
Financial
Blink Charging Co
5.22%
-1.39%
-4.37%
350.68M
Industrials
Assertio Therapeutics
2.90%
-1.65%
-4.97%
146.49M
Healthcare
GE Aerospace
5.17%
-0.65%
+1.07%
174.66B
Industrials
Bristol-Myers Squibb
3.17%
-0.64%
+1.88%
81.39B
Healthcare
AMC Entertainment
5.71%
-1.59%
-3.18%
1.58B
Communication Services
Marathon Digital Holdings
5.54%
-0.51%
+0.25%
6.71B
Financial
Plug Power
5.06%
-0.92%
-2.43%
2.38B
Industrials
Based on the activity of 746,321 active portfolios
Open your Smart Portfolio

CANF Investor Analysis

CANF investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
11.1%
of CANF holders
are under 35
Average Segment Performance
Average P/E Ratio21.96
Beta7.16
Dividend Yield6.43%
CANF investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
61.1%
of CANF holders
are between 35–55
Average Segment Performance
Average P/E Ratio20.75
Beta11.80
Dividend Yield6.41%
CANF investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
27.8%
of CANF holders
are over 55
Average Segment Performance
Average P/E Ratio20.82
Beta3.95
Dividend Yield7.83%
Overview of age group and performance of CANF stock investors
See who invests in CANF according to age group and performance.

FAQ

How many retail Investors hold CANF?
<0.1% of TipRanks' retail investors hold CANF in their portfolios.
    What is CANF Investor Sentiment?
    CANF’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of CANF in the last 7 days?
      ▼ 6.2% of TipRanks' retail investors changed their holding of CANF in the last 7 days.
        What percentage of retail investors changed their holding of CANF in the last 30 days?
        ▲ 17.1% of TipRanks' retail investors changed their holding of CANF in the last 30 days.
          What is the average age of retail investors who hold CANF?
          The average age of CANF Holders is between 35–55.
            What other stocks have CANF investors also bought?
            CANF Investors also bought DKNG, CHPT, RIOT, BLNK, ASRT, GE, BMY, AMC, MARA, PLUG.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALGNAlign Tech
              BCRXBioCryst
              BSXBoston Scientific
              CYTKCytokinetics
              EWEdwards Lifesciences
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis